ALEXIS PILGRIM: Open Payments
NPI 1316618309 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 44 payments from 15 companies in 2025. Trend: 2023 $1,019 · 2024 $1,092 · 2025 $1,133
Food & beverage: $848Education: $285
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $220 |
| Janssen Biotech, Inc. | 6 | $197 |
| AstraZeneca Pharmaceuticals LP | 4 | $146 |
| Astellas Pharma US Inc | 3 | $116 |
| SEAGEN INC. | 1 | $99 |
| Exelixis Inc. | 4 | $65 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| BeOne Medicines USA, Inc. | 2 | $42 |
| Incyte Corporation | 2 | $39 |
| ABBVIE INC. | 2 | $39 |
Products named: RYBREVANT, PLUVICTO, CABOMETYX, KEYTRUDA, ERLEADA, SCEMBLIX, Fabhalta, BRUKINSA.
Industry payments across AR — which companies pay providers there.
